Annual FCF
-$9.56 M
-$4.01 M-72.20%
December 31, 2023
Summary
- As of March 6, 2025, SBFM annual free cash flow is -$9.56 million, with the most recent change of -$4.01 million (-72.20%) on December 31, 2023.
- During the last 3 years, SBFM annual FCF has fallen by -$8.90 million (-1352.27%).
- SBFM annual FCF is now -308390.32% below its all-time high of -$3100.00, reached on July 1, 2007.
Performance
SBFM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.97 M
+$3.18 M+61.74%
September 30, 2024
Summary
- As of March 6, 2025, SBFM quarterly free cash flow is -$1.97 million, with the most recent change of +$3.18 million (+61.74%) on September 30, 2024.
- Over the past year, SBFM quarterly FCF has stayed the same.
- SBFM quarterly FCF is now -265.83% below its all-time high of $1.19 million, reached on June 1, 2010.
Performance
SBFM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$14.00 M
-$1.50 M-12.01%
September 30, 2024
Summary
- As of March 6, 2025, SBFM TTM free cash flow is -$14.00 million, with the most recent change of -$1.50 million (-12.01%) on September 30, 2024.
- Over the past year, SBFM TTM FCF has stayed the same.
- SBFM TTM FCF is now -1670.26% below its all-time high of $891.50 thousand, reached on March 1, 2011.
Performance
SBFM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
SBFM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -72.2% | 0.0% | 0.0% |
| 3 y3 years | -1352.3% | 0.0% | 0.0% |
| 5 y5 years | -1698.6% | 0.0% | 0.0% |
SBFM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -422.8% | at low | -320.1% | +61.7% | -401.6% | at low |
| 5 y | 5-year | -1825.3% | at low | -6256.4% | +61.7% | -4666.4% | at low |
| alltime | all time | <-9999.0% | at low | -265.8% | +61.7% | -1670.3% | at low |
Sunshine Biopharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.97 M(-61.7%) | -$14.00 M(+12.0%) |
| Jun 2024 | - | -$5.15 M(+32.6%) | -$12.50 M(+9.4%) |
| Mar 2024 | - | -$3.88 M(+29.8%) | -$11.42 M(+19.4%) |
| Dec 2023 | -$9.56 M(+72.2%) | -$2.99 M(+538.1%) | -$9.56 M(+8.5%) |
| Sep 2023 | - | -$469.10 K(-88.5%) | -$8.82 M(-6.9%) |
| Jun 2023 | - | -$4.07 M(+100.8%) | -$9.47 M(+58.6%) |
| Mar 2023 | - | -$2.03 M(-9.7%) | -$5.97 M(+13.8%) |
| Dec 2022 | -$5.55 M(+203.6%) | -$2.25 M(+99.9%) | -$5.25 M(+58.4%) |
| Sep 2022 | - | -$1.12 M(+95.8%) | -$3.31 M(+18.7%) |
| Jun 2022 | - | -$573.80 K(-56.0%) | -$2.79 M(-1.6%) |
| Mar 2022 | - | -$1.30 M(+317.9%) | -$2.84 M(+55.0%) |
| Dec 2021 | -$1.83 M(+177.8%) | - | - |
| Dec 2021 | - | -$312.10 K(-48.1%) | -$1.83 M(-5.8%) |
| Sep 2021 | - | -$600.80 K(-2.9%) | -$1.94 M(+32.8%) |
| Jun 2021 | - | -$618.90 K(+108.1%) | -$1.46 M(+58.0%) |
| Mar 2021 | - | -$297.40 K(-29.9%) | -$924.90 K(+40.5%) |
| Dec 2020 | -$658.50 K(+32.6%) | -$424.10 K(+249.3%) | -$658.50 K(+81.4%) |
| Sep 2020 | - | -$121.40 K(+48.0%) | -$363.10 K(+10.8%) |
| Jun 2020 | - | -$82.00 K(+164.5%) | -$327.80 K(+11.6%) |
| Mar 2020 | - | -$31.00 K(-75.9%) | -$293.70 K(-40.9%) |
| Dec 2019 | -$496.70 K(-6.6%) | -$128.70 K(+49.5%) | -$496.70 K(+4.5%) |
| Sep 2019 | - | -$86.10 K(+79.7%) | -$475.50 K(-15.9%) |
| Jun 2019 | - | -$47.90 K(-79.5%) | -$565.30 K(-4.6%) |
| Mar 2019 | - | -$234.00 K(+117.7%) | -$592.40 K(+11.4%) |
| Dec 2018 | -$531.70 K(-2.8%) | -$107.50 K(-38.9%) | -$531.60 K(-16.6%) |
| Sep 2018 | - | -$175.90 K(+134.5%) | -$637.30 K(+8.5%) |
| Jun 2018 | - | -$75.00 K(-56.7%) | -$587.30 K(-4.1%) |
| Mar 2018 | - | -$173.20 K(-18.8%) | -$612.40 K(+11.9%) |
| Dec 2017 | -$547.20 K(+72.3%) | -$213.20 K(+69.3%) | -$547.20 K(+49.4%) |
| Sep 2017 | - | -$125.90 K(+25.8%) | -$366.30 K(+20.7%) |
| Jun 2017 | - | -$100.10 K(-7.3%) | -$303.40 K(-11.8%) |
| Mar 2017 | - | -$108.00 K(+234.4%) | -$344.00 K(+8.3%) |
| Dec 2016 | -$317.60 K | -$32.30 K(-48.7%) | -$317.60 K(-49.4%) |
| Sep 2016 | - | -$63.00 K(-55.2%) | -$628.10 K(-5.9%) |
| Jun 2016 | - | -$140.70 K(+72.4%) | -$667.70 K(-20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$81.60 K(-76.2%) | -$836.20 K(-3.6%) |
| Dec 2015 | -$1.49 M(+176.9%) | -$342.80 K(+234.1%) | -$867.60 K(+12.3%) |
| Sep 2015 | - | -$102.60 K(-66.8%) | -$772.50 K(+12.3%) |
| Jun 2015 | - | -$309.20 K(+173.6%) | -$688.00 K(+22.7%) |
| Mar 2015 | - | -$113.00 K(-54.4%) | -$560.80 K(+4.1%) |
| Dec 2014 | -$538.60 K(-4.6%) | -$247.70 K(+1268.5%) | -$538.60 K(+62.9%) |
| Sep 2014 | - | -$18.10 K(-90.1%) | -$330.60 K(-17.0%) |
| Jun 2014 | - | -$182.00 K(+100.4%) | -$398.10 K(+26.2%) |
| Mar 2014 | - | -$90.80 K(+128.7%) | -$315.40 K(-44.1%) |
| Dec 2013 | -$564.40 K(+43.6%) | -$39.70 K(-53.6%) | -$564.30 K(-19.1%) |
| Sep 2013 | - | -$85.60 K(-13.8%) | -$697.40 K(-9.7%) |
| Jun 2013 | - | -$99.30 K(-70.8%) | -$772.10 K(+10.6%) |
| Mar 2013 | - | -$339.70 K(+96.6%) | -$698.00 K(+77.6%) |
| Dec 2012 | -$393.10 K(+32.2%) | -$172.80 K(+7.8%) | -$393.10 K(+16.3%) |
| Sep 2012 | - | -$160.30 K(+536.1%) | -$338.10 K(+14.1%) |
| Jun 2012 | - | -$25.20 K(-27.6%) | -$296.20 K(+2.9%) |
| Mar 2012 | - | -$34.80 K(-70.5%) | -$287.80 K(-3.2%) |
| Dec 2011 | -$297.30 K(-14.6%) | -$117.80 K(-0.5%) | -$297.30 K(-29.9%) |
| Sep 2011 | - | -$118.40 K(+604.8%) | -$423.90 K(+35.2%) |
| Jun 2011 | - | -$16.80 K(-62.1%) | -$313.60 K(-135.2%) |
| Mar 2011 | - | -$44.30 K(-81.9%) | $891.50 K(-356.0%) |
| Dec 2010 | -$348.30 K(-35.1%) | -$244.40 K(+2917.3%) | -$348.30 K(+235.2%) |
| Sep 2010 | - | -$8100.00(-100.7%) | -$103.90 K(-81.6%) |
| Jun 2010 | - | $1.19 M(-192.5%) | -$565.00 K(-67.8%) |
| Mar 2010 | - | -$1.28 M(+173.7%) | -$1.75 M(+270.6%) |
| Dec 2009 | -$536.90 K(+5163.7%) | - | - |
| Oct 2009 | - | -$469.20 K(>+9900.0%) | -$473.50 K(+4542.2%) |
| Jul 2009 | -$10.20 K(-55.7%) | -$1500.00(-21.1%) | -$10.20 K(-8.9%) |
| Apr 2009 | - | -$1900.00(+111.1%) | -$11.20 K(-43.4%) |
| Jan 2009 | - | -$900.00(-84.7%) | -$19.80 K(-9.6%) |
| Oct 2008 | - | -$5900.00(+136.0%) | -$21.90 K(-4.8%) |
| Jul 2008 | -$23.00 K(+641.9%) | -$2500.00(-76.2%) | -$23.00 K(+12.2%) |
| Apr 2008 | - | -$10.50 K(+250.0%) | -$20.50 K(+105.0%) |
| Jan 2008 | - | -$3000.00(-57.1%) | -$10.00 K(+42.9%) |
| Oct 2007 | - | -$7000.00 | -$7000.00 |
| Jul 2007 | -$3100.00 | - | - |
FAQ
- What is Sunshine Biopharma annual free cash flow?
- What is the all time high annual FCF for Sunshine Biopharma?
- What is Sunshine Biopharma annual FCF year-on-year change?
- What is Sunshine Biopharma quarterly free cash flow?
- What is the all time high quarterly FCF for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly FCF year-on-year change?
- What is Sunshine Biopharma TTM free cash flow?
- What is the all time high TTM FCF for Sunshine Biopharma?
- What is Sunshine Biopharma TTM FCF year-on-year change?
What is Sunshine Biopharma annual free cash flow?
The current annual FCF of SBFM is -$9.56 M
What is the all time high annual FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high annual free cash flow is -$3100.00
What is Sunshine Biopharma annual FCF year-on-year change?
Over the past year, SBFM annual free cash flow has changed by -$4.01 M (-72.20%)
What is Sunshine Biopharma quarterly free cash flow?
The current quarterly FCF of SBFM is -$1.97 M
What is the all time high quarterly FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly free cash flow is $1.19 M
What is Sunshine Biopharma quarterly FCF year-on-year change?
Over the past year, SBFM quarterly free cash flow has changed by $0.00 (0.00%)
What is Sunshine Biopharma TTM free cash flow?
The current TTM FCF of SBFM is -$14.00 M
What is the all time high TTM FCF for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM free cash flow is $891.50 K
What is Sunshine Biopharma TTM FCF year-on-year change?
Over the past year, SBFM TTM free cash flow has changed by $0.00 (0.00%)